Overall Technical outlook

Price Summary

The stock of Jubilant Pharmova Limited experienced a -5.01% crash, showcasing a lacklustre market performance.
On 2025-04-25, JUBLPHARMA's stock opened at 958.0, reached a peak of 962.0, dropped to 901.0, and ended -5.01% lower at 910.0, with a volume of 435484 shares.
The top price for the stock in the last 52 weeks is 1254.55, with the bottom price being 640.95.

Technicals

Support and Resistance: The current price of 910.0 is supported at 881.95, with resistance at 941.6. This suggests that the price for JUBLPHARMA might remain between these levels, where 881.95 acts as a floor and 941.6 as a ceiling in the market.
JUBLPHARMA supportResistance 7e1f24
Support/Resistance for JUBLPHARMA


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
JUBLPHARMA aroon 7e1f24
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
JUBLPHARMA bbands 7e1f24
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
JUBLPHARMA psar 7e1f24
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The current state of the STOCHASTIC is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
JUBLPHARMA stoch 7e1f24
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
JUBLPHARMA trippleSMA 7e1f24
Tripple SMA chart for Jubilant Pharmova Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.